Is a complete APMD research report available?

No complete published report is available for Apnimed, Inc. (APMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Apnimed, Inc. (APMD)

NASDAQ: APMD · USD

$19.0

-0.49 (-2.5%)· Recorded snapshot

Market cap	791M
Revenue (ttm)	115.1M
Net income (ttm)	163.6M
EPS (ttm)	$8.49
Shares out	41.6M
P/E (trailing)	2.2x
Volume	295,470

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 115.1M
Net income (ttm): 163.6M
EPS (ttm): $8.49
P/E (trailing): 2.2x
Market cap: 791M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001745648
Company name	Apnimed, Inc.
Country	United States
Country code	US
CUSIP number	03770Y107
Earnings date	2026-11-10
Earnings time	amc
Employees	81
Enterprise value	$708.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-08-01
Fiscal year end	December
Founded	2017
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2026-07-31
Is primary listing	Yes
Is SPAC	No
ISIN number	US03770Y1073
Last earnings date	2026-09-08
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$791M
Market cap category	Small-Cap
Next earnings date	2026-11-10
Options	No
Price	$19.00
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	APMD
U.S. state	Massachusetts
Website	https://apnimed.com

Metric

Value

Amount currency

USD

CIK code

0001745648

Company name

Apnimed, Inc.

Country

United States

Country code

CUSIP number

03770Y107

Earnings date

2026-11-10

Earnings time

amc

Employees

Enterprise value

$708.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-08-01

Fiscal year end

December

Founded

2017

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2026-07-31

Is primary listing

Yes

Is SPAC

ISIN number

US03770Y1073

Last earnings date

2026-09-08

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$791M

Market cap category

Small-Cap

Next earnings date

2026-11-10

Options

Price

$19.00

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

APMD

U.S. state

Massachusetts

Website

https://apnimed.com

Metric	Value
Earnings yield	44.69%
EV/Earnings	4.43x
EV/EBIT	20.21x
EV/EBITDA	20.19x
EV/Sales	6.3x
FCF / EV yield	-9.65%
FCF yield	-8.66%
Forward EV/Sales	1,449.6x
Forward P/S	1,614.44x
P/B ratio	11.57x
P/E ratio	2.24x
P/S ratio	7.01x
Price/EBITDA ratio	22.49x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

44.69%

EV/Earnings

4.43x

EV/EBIT

20.21x

EV/EBITDA

20.19x

EV/Sales

6.3x

FCF / EV yield

-9.65%

FCF yield

-8.66%

Forward EV/Sales

1,449.6x

Forward P/S

1,614.44x

P/B ratio

11.57x

P/E ratio

2.24x

P/S ratio

7.01x

Price/EBITDA ratio

22.49x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	31.16%
EBITDA margin	31.18%
Gross margin	93.9%
Operating margin	31.16%
Pretax margin	148.32%
Profit margin	142.1%
Profit per employee	$2M
Profitable quarters	2
Revenue per employee	$1.4M
ROCE	22.44%
SBC / revenue	3.79%

Metric

Value

EBIT margin

31.16%

EBITDA margin

31.18%

Gross margin

93.9%

Operating margin

31.16%

Pretax margin

148.32%

Profit margin

142.1%

Profit per employee

$2M

Profitable quarters

Revenue per employee

$1.4M

ROCE

22.44%

SBC / revenue

3.79%

Metric	Value
EPS growth (QoQ)	157.16%
EPS growth quarters	1
EPS growth years	0
Net income growth (QoQ)	85.97%
Net income growth quarters	1
Net income growth years	0
Revenue growth	380.12%
Revenue growth (Q)	-29.4%
Revenue growth (QoQ)	-85.76%
Revenue growth quarters	1
Revenue growth years	1

Metric

Value

EPS growth (QoQ)

157.16%

EPS growth quarters

EPS growth years

Net income growth (QoQ)

85.97%

Net income growth quarters

Net income growth years

Revenue growth

380.12%

Revenue growth (Q)

-29.4%

Revenue growth (QoQ)

-85.76%

Revenue growth quarters

Revenue growth years

Metric	Value
Depreciation and amortization	$27,000
EBIT	$35.9M
EBITDA	$35.9M
EPS	$8.49
FCF per share	$-1.68
Financing cash flow	$104.3M
Free cash flow	$-69.9M
Free cash flow minus SBC	$-74.3M
Gross profit	$108.1M
Investing cash flow	$99.7M
Net borrowing	$83.2M
Net cash flow	$134M
Net income	$163.6M
Operating cash flow minus SBC	$-74.3M
Operating income	$35.9M
Revenue	$115.1M
Stock-based compensation	$4.4M

Metric

Value

Depreciation and amortization

$27,000

EBIT

$35.9M

EBITDA

$35.9M

EPS

$8.49

FCF per share

$-1.68

Financing cash flow

$104.3M

Free cash flow

$-69.9M

Free cash flow minus SBC

$-74.3M

Gross profit

$108.1M

Investing cash flow

$99.7M

Net borrowing

$83.2M

Net cash flow

$134M

Net income

$163.6M

Operating cash flow minus SBC

$-74.3M

Operating income

$35.9M

Revenue

$115.1M

Stock-based compensation

$4.4M

Metric	Value
Altman Z-Score	0.65
Book value per share	$-36.69
Debt / EBITDA	2.49
Debt / equity	1.3
Interest coverage	12.61
Long-term assets	$10.7M
Long-term liabilities	$90.1M
Net cash (debt)	$82.4M
Net cash / market cap	10.21%
Net debt / EBITDA	-2.3
Net debt / equity	-1.18
Piotroski F-Score	1
Property, plant and equipment	$767,000
Shareholders' equity	$69.8M
Tangible book value	$-176.2M
Tangible book value per share	$-36.69
Total assets	$195.5M
Total cash	$172.8M
Total debt	$90.4M
Total liabilities	$125.7M

Metric

Value

Altman Z-Score

0.65

Book value per share

$-36.69

Debt / EBITDA

2.49

Debt / equity

1.3

Interest coverage

12.61

Long-term assets

$10.7M

Long-term liabilities

$90.1M

Net cash (debt)

$82.4M

Net cash / market cap

10.21%

Net debt / EBITDA

-2.3

Net debt / equity

-1.18

Piotroski F-Score

Property, plant and equipment

$767,000

Shareholders' equity

$69.8M

Tangible book value

$-176.2M

Tangible book value per share

$-36.69

Total assets

$195.5M

Total cash

$172.8M

Total debt

$90.4M

Total liabilities

$125.7M

Metric	Value
Current assets	$184.8M
Current liabilities	$35.6M
Current ratio	5.19
Net working capital	$-23.3M
Quick ratio	4.88
Working capital	$149.2M

Metric

Value

Current assets

$184.8M

Current liabilities

$35.6M

Current ratio

5.19

Net working capital

$-23.3M

Quick ratio

4.88

Working capital

$149.2M

Metric	Value
Buyback yield / dilution	-562.85%
Dividend yield	0%
Shareholder yield	-562.85%

Metric

Value

Buyback yield / dilution

-562.85%

Dividend yield

Shareholder yield

-562.85%

Metric	Value
1D price change	-2.51%
1M price change	-11.1%
1M total return	-11.1%
1W price change	1.3%
1W total return	1.3%
20-day SMA	$18.88
50-day SMA	$23.46
52-week high	$35.29
52-week high date	2026-08-18
52-week low	$16.12
52-week low date	2026-07-31
All-time high	$35.29
All-time high date	2026-08-18
All-time low	$16.12
All-time low date	2026-07-31
Average true range (ATR)	$1.86
Average volume	377.8K
Beta (1Y)	0.92
Change from 52-week high	-46.16%
Change from 52-week low	17.87%
Change from all-time high	-46.87%
Change from all-time low	16.32%
Change from open	-0.99%
Day's gap	-1.54%
Dollar volume	$5.6M
High price	$19.39
Low price	$17.93
Monthly RSI	0
Open price	$19.19
Position in 52-week range	73.29%
Premarket change	11.85%
Premarket close	$19.49
Premarket price	$21.80
Previous close	$19.49
Price vs 20-day SMA	-0.7%
Price vs 50-day SMA	-20.08%
Relative volume	0.78
Return from IPO open	-11.86%
Return from IPO price	21.19%
RSI	42.98
Sharpe ratio	-0.88
Sortino ratio	-1.09
Volume	295.5K
Weekly RSI	0

Metric

Value

1D price change

-2.51%

1M price change

-11.1%

1M total return

-11.1%

1W price change

1.3%

1W total return

1.3%

20-day SMA

$18.88

50-day SMA

$23.46

52-week high

$35.29

52-week high date

2026-08-18

52-week low

$16.12

52-week low date

2026-07-31

All-time high

$35.29

All-time high date

2026-08-18

All-time low

$16.12

All-time low date

2026-07-31

Average true range (ATR)

$1.86

Average volume

377.8K

Beta (1Y)

0.92

Change from 52-week high

-46.16%

Change from 52-week low

17.87%

Change from all-time high

-46.87%

Change from all-time low

16.32%

Change from open

-0.99%

Day's gap

-1.54%

Dollar volume

$5.6M

High price

$19.39

Low price

$17.93

Monthly RSI

Open price

$19.19

Position in 52-week range

73.29%

Premarket change

11.85%

Premarket close

$19.49

Premarket price

$21.80

Previous close

$19.49

Price vs 20-day SMA

-0.7%

Price vs 50-day SMA

-20.08%

Relative volume

0.78

Return from IPO open

-11.86%

Return from IPO price

21.19%

RSI

42.98

Sharpe ratio

-0.88

Sortino ratio

-1.09

Volume

295.5K

Weekly RSI

Metric	Value
Float	20.5M
Float percentage	49.14%
Shares change (QoQ)	-24.89%
Shares change (YoY)	562.85%
Shares held by insiders	1.27%
Shares held by institutions	21.72%
Shares outstanding	41.6M
Short % of float	8.63%
Short % of shares	4.24%
Short ratio	3.1 days

Metric

Value

Float

20.5M

Float percentage

49.14%

Shares change (QoQ)

-24.89%

Shares change (YoY)

562.85%

Shares held by insiders

1.27%

Shares held by institutions

21.72%

Shares outstanding

41.6M

Short % of float

8.63%

Short % of shares

4.24%

Short ratio

3.1 days

Apnimed, Inc. (APMD)

Price

Financial snapshot

Fair-value bridge

Latest news · APMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All APMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on APMD

Frequently asked questions